Antibody Drug Conjugates Market
ADCs, or antibody drug conjugates, are a new class of extremely potent biopharmaceutical drugs that contain an antibody connected to a cytotoxic or biologically active substance by a chemical linker. These targeted agents combine the potent cell-killing properties of cytotoxic drugs with the distinct and highly sensitive targeting capabilities of antibodies, allowing sensitive discrimination between healthy and cancerous tissues.
Read More:
https://cmitoc.blogspot.com/2022/11/antibody-drug-conjugates-drugs-designed.html
